MedTrace Logo

Near-Infrared Light Photobiomodulation Treatment for Retinal Vein Occlusion Macular Oedema

NCT04847869 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2021-04-19

No results posted yet for this study

Summary

This pilot study aims to establish that treatment with near infrared light (NIR) reduces cystic macular oedema in patients with a retinal vein occlusion.

Conditions

  • Macula Edema
  • Retinal Vein Occlusion

Interventions

DEVICE

Ellex Integre NIR laser

The Ellex Integre NIR (near Infrared Light) Laser dose of 200 mW/cm2 for 90 seconds for 12 treatments at 2 to 3 day intervals over 5 weeks.

Sponsors & Collaborators

  • University of Sydney

    lead OTHER

Principal Investigators

  • Elisa E Cornish, MBBS PhD · University of Sydney

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-12-31
Completion
2022-07-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04847869 on ClinicalTrials.gov